Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains
- PMID: 22843783
- PMCID: PMC3657521
- DOI: 10.1093/cid/cis574
Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains
Abstract
Background: Influenza vaccines may be reformulated annually because of antigenic drift in influenza viruses. However, the relationship between antigenic characteristics of circulating viruses and vaccine effectiveness (VE) is not well understood. We conducted an assessment of the effectiveness of US influenza vaccines during the 2010-2011 season.
Methods: We performed a case-control study comparing vaccination histories between subjects with acute respiratory illness with positive real-time reverse transcription polymerase chain reaction for influenza and influenza test-negative controls. Subjects with acute respiratory illness of ≤7 days duration were enrolled in hospitals, emergency departments, or outpatient clinics in communities in 4 states. History of immunization with the 2010-2011 vaccine was ascertained from vaccine registries or medical records. Vaccine effectiveness was estimated in logistic regression models adjusted for study community, age, race, insurance status, enrollment site, and presence of a high-risk medical condition.
Results: A total of 1040 influenza-positive cases and 3717 influenza-negative controls were included from the influenza season, including 373 cases of influenza A(H1N1), 334 cases of influenza A(H3N2), and 333 cases of influenza B. Overall adjusted VE was 60% (95% confidence interval [CI], 53%-66%). Age-specific VE estimates ranged from 69% (95% CI, 56%-77%) in children aged 6 months-8 years to 38% (95% CI, -16% to 67%) in adults aged ≥65 years.
Conclusions: The US 2010-2011 influenza vaccines were moderately effective in preventing medically attended influenza during a season when all 3 vaccine strains were antigenically similar to circulating viruses. Continued monitoring of influenza vaccines in all age groups is important, particularly as new vaccines are introduced.
Figures
Similar articles
-
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.Clin Infect Dis. 2014 Feb;58(3):319-27. doi: 10.1093/cid/cit736. Epub 2013 Nov 13. Clin Infect Dis. 2014. PMID: 24235265 Free PMC article.
-
Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):10-5. MMWR Morb Mortal Wkly Rep. 2015. PMID: 25590680 Free PMC article.
-
Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016.Influenza Other Respir Viruses. 2020 Jul;14(4):380-390. doi: 10.1111/irv.12741. Epub 2020 Apr 16. Influenza Other Respir Viruses. 2020. PMID: 32298048 Free PMC article.
-
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.Expert Rev Vaccines. 2014 Dec;13(12):1571-91. doi: 10.1586/14760584.2014.966695. Epub 2014 Oct 28. Expert Rev Vaccines. 2014. PMID: 25348015 Free PMC article. Review.
-
Immune History and Influenza Vaccine Effectiveness.Vaccines (Basel). 2018 May 21;6(2):28. doi: 10.3390/vaccines6020028. Vaccines (Basel). 2018. PMID: 29883414 Free PMC article. Review.
Cited by
-
Multi-strain modeling of influenza vaccine effectiveness in older adults and its dependence on antigenic distance.Sci Rep. 2024 Nov 8;14(1):27190. doi: 10.1038/s41598-024-72716-1. Sci Rep. 2024. PMID: 39516205 Free PMC article.
-
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States.Elife. 2024 Sep 25;13:RP91849. doi: 10.7554/eLife.91849. Elife. 2024. PMID: 39319780 Free PMC article.
-
Immunogenicity of Enhanced Influenza Vaccines Against Mismatched Influenza Strains in Older Adults: A Review of Randomized Controlled Trials.Influenza Other Respir Viruses. 2024 Apr;18(4):e13286. doi: 10.1111/irv.13286. Influenza Other Respir Viruses. 2024. PMID: 38594827 Free PMC article. Review.
-
Color-Flu Fluorescent Reporter Influenza A Viruses Allow for In Vivo Studies of Innate Immune Function in Zebrafish.Viruses. 2024 Jan 20;16(1):155. doi: 10.3390/v16010155. Viruses. 2024. PMID: 38275965 Free PMC article.
-
Nanoparticles and Antiviral Vaccines.Vaccines (Basel). 2023 Dec 27;12(1):30. doi: 10.3390/vaccines12010030. Vaccines (Basel). 2023. PMID: 38250843 Free PMC article. Review.
References
-
- Orenstein EW, de Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36:623–31. - PubMed
-
- Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2010;59:1–62. - PubMed
-
- Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA. Evaluation of self-reported and registry-based influena vaccination status in a Wisconsin cohort. Vaccine. 2009;27:6543–9. - PubMed
-
- Kendal A, Pereira M, Skehel J. Hemagglutination-inhibtion: concepts and procedures for laboratory-based influenza surveillance. 1982 US Department of Health and Human Services, Atlanta GA.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
